1. Home
  2. GNSS vs AFMD Comparison

GNSS vs AFMD Comparison

Compare GNSS & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNSS
  • AFMD
  • Stock Information
  • Founded
  • GNSS 1992
  • AFMD 2000
  • Country
  • GNSS United States
  • AFMD Germany
  • Employees
  • GNSS N/A
  • AFMD N/A
  • Industry
  • GNSS Consumer Electronics/Appliances
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNSS Consumer Staples
  • AFMD Health Care
  • Exchange
  • GNSS Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • GNSS 169.5M
  • AFMD 53.3M
  • IPO Year
  • GNSS N/A
  • AFMD 2014
  • Fundamental
  • Price
  • GNSS $3.75
  • AFMD $3.36
  • Analyst Decision
  • GNSS Strong Buy
  • AFMD Strong Buy
  • Analyst Count
  • GNSS 3
  • AFMD 5
  • Target Price
  • GNSS $5.08
  • AFMD $16.25
  • AVG Volume (30 Days)
  • GNSS 106.7K
  • AFMD 80.0K
  • Earning Date
  • GNSS 12-05-2024
  • AFMD 11-12-2024
  • Dividend Yield
  • GNSS N/A
  • AFMD N/A
  • EPS Growth
  • GNSS N/A
  • AFMD N/A
  • EPS
  • GNSS N/A
  • AFMD N/A
  • Revenue
  • GNSS $27,968,000.00
  • AFMD $7,959,927.00
  • Revenue This Year
  • GNSS N/A
  • AFMD N/A
  • Revenue Next Year
  • GNSS $138.10
  • AFMD $48.98
  • P/E Ratio
  • GNSS N/A
  • AFMD N/A
  • Revenue Growth
  • GNSS N/A
  • AFMD N/A
  • 52 Week Low
  • GNSS $1.51
  • AFMD $2.92
  • 52 Week High
  • GNSS $4.04
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • GNSS 60.29
  • AFMD 44.84
  • Support Level
  • GNSS $3.67
  • AFMD $3.28
  • Resistance Level
  • GNSS $3.94
  • AFMD $3.51
  • Average True Range (ATR)
  • GNSS 0.14
  • AFMD 0.17
  • MACD
  • GNSS -0.02
  • AFMD 0.04
  • Stochastic Oscillator
  • GNSS 77.78
  • AFMD 55.79

About GNSS Genasys Inc.

Genasys Inc is a provider of critical communications solutions designed to help keep people safe. The company is engaged in the design, development, and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. Its operating segment includes Hardware and Software. The company generates maximum revenue from the Hardware segment. Geographically, it derives a majority of revenue from the Americas region and also has its presence in the Asia Pacific and Europe, Middle East and Africa.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: